Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment ...

It's uncommon in women under the age of 45. This cancer is more common in Black women than in White women. Incidence rates have increased by more than1% per year since the mid-2000s. Over the past ...

Federal Reserve Chair Jerome Powell told lawmakers on Tuesday the argument for free trade still makes sense but added that it was not the role of the central bank to comment on tariff or trade policy ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

Radiation dose intensification improves pathologic complete response rates in locally advanced rectal cancer but also leads ...

Better access and capability scores were associated with integrated practice ownership and participation in accountable care ...

Researchers have used mathematical analysis tools to study the effect of classical music on a fetal heartbeat and identify patterns in heart rate variability. They recruited 36 pregnant women and ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

Marwan G. Fakih, MD, provides an overview of the study design, rationale, and findings from a phase 2 trial of balstilimab with botensilimab for the treatment of patients with microsatellite stable ...

Already, Lal said his team has seen improvement: with about 2,000 active applicants across 34 open roles — all handled by four recruiters — they’ve seen their time to hire drop by 43% from the year ...